Sevag Sahakian

Passionate and results-oriented pharmaceutical senior leader with over 15 years of experience in Medical Affairs, Policy, Public Health, and Pharmacy. Known for delivering valued and patient-centric outcomes across various therapeutic areas. Recognized for advanced team-building acumen, driving success in product development, launches, and growth while navigating the intricacies of the Canadian HTA, procurement, scientific, and Public Health environments. Skilled in fostering strong relationships within medical and government circles, with a focus on patient advocacy.

• 2023, 2024, First Vice-Chair, BIOTEC Canada’s Vaccines Industry Committee
• 2023, 2024, Steering Committee Member, Adult Vaccine Alliance, https://www.adultvaccinealliance.ca/about

• Post-switch Effectiveness of Etanercept Biosimilar Versus Continued Etanercept in Rheumatoid Arthritis Patients with Stable Disease: A Prospective Multinational Observational Study, Adv Ther, 2022, https://link.springer.com/article/10.1007/s12325-022-02303-1
• Canadian Health Care Professionals’ Familiarity with Chronic Cough Guidelines and Experiences with Diagnosis and Management: A Cross-Sectional Survey, Lung, 2023, https://link.springer.com/article/10.1007/s00408-023-00604-y